NECTIN3 and cancer: TME of RMS is notably immunosuppressive, marked by an abundance of regulatory T cells (Tregs) and the expression of immune checkpoint molecules such as TIGIT, which interact with NECTIN3 on cancer cells, potentially leading to T‐cell dysfunction.32